Quality of life questionnaires

Home/Assessment/Outcome Measures/Quality of life questionnaires
Quality of life questionnaires 2017-04-27T04:43:47+00:00

 

Quality of Life

The following Quality of Life questionnaires have been validated for bronchiectasis:

 A licensing agreement and fee is required to use the questionnaire. 

Please contact:

Jane Howe, Licensing Officer

Office of Research Contracts & Intellectual Property

McMaster University, GH 306G

1280 Main Street, W.

Hamilton, Ontario, CANADA L8S 4L8

Telephone: 1-877-836-9235

Fax: 905-540-8019

Email: orcip@mcmaster.ca

A licensing agreement and fee is required to use the questionnaire.

Contact Yvonne Forde at sgrq@sgul.ac.uk

St George’s Health Status Research Team

Dept of Physiologicia Medicine

St George’s Hospital Medical School

London SW17 ORE  UK

St George Respiratory Questionnaire

Systematic review and meta-analysis of health-related quality of life questionnaires in bronchiectasis – Spinou et al 2015.

Choosing an appropriate quality of life outcome measure

For clinicians measuring the disease-specific effects of bronchiectasis, the most optimal choice is the Quality of Life – Bronchiectasis (QOL-B). This provides a broad and detailed measure of quality of life overall, which encompasses all aspects of the condition. It may also be useful for examining the effects of different treatments, including medication and physiotherapy interventions.

For clinicians measuring the respiratory effects of bronchiectasis on quality of life, either the St George’s Respiratory Questionnaire or the Chronic Respiratory Questionnaire are a suitable choice. Both have been applied as outcomes measures for physiotherapy interventions (airway clearance therapy and pulmonary rehabilitation) and in medication trials of antibiotic therapy.

For clinicians specifically interested in the cough-related effects of bronchiectasis on quality of life, the Leicester Cough Questionnaire is a suitable choice. It has been applied as an outcome measure for physiotherapy (airway clearance therapy and pulmonary rehabilitation) and medication trials of antibiotic therapy.

For people with Primary Ciliary Dyskinesia – QOL-PCD (Lucas et al 2015).

References